Today’s tickers: BSX, WPI, SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
BSX- Implied volatility in the maker of “less invasive” medical instruments, Boston Scientific Corp, is elevated at 45.4% (compared to 33.8% historic) ahead of its after-the-bell earnings report as shares trade flat at $13.84. An increase in options trading volume to nearly 8 times the normal level shows traders eschewing the front month, however, and entering 10,000 lot positions in November 15 calls for 90 cents, and again at what looks like the January 10/17.50 collar or strangle. If the January volume was a strangle, it would have been a short position favoring rangebound activity between the strike prices with a 75-cent credit hanging in the balance. A collar at these strikes given the order flow would also have been short, with a trader selling the 10-strike puts and buying the 17.50-strike calls to protect a short position in the stock. Boston Scientific shares are up 19.6% for the year to date.
WPI- Last week’s much-ballyhooed buyout of Barr Pharmaceuticals by Israeli sector peer Teva, and this morning’s offer by Roche to acquire the remaining stake in Genentech has option traders looking for the next possible takeout target. To that end we’re look at options activity in Watson Pharmaceuticals, which we should be careful to stipulate has no specific rumor tied to its stock, but where some option traders showed an unusual interest in out-of-the-money calls today. With shares down 2.5% to $29.13 we registered an increase in option trading volume to nearly 10 times the normal level, situated in November 35-strike calls, which were bought for 40 cents. Given that Watson shares have traded as low as $23.90 and as … 













Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...